Dec 17 - By Linda A. Johnson, AP Business Writer
Merck & Co. said Thursday it is making another deal in its strategy to become a top maker of biotech drugs, buying a British company that makes them.
Oct 23 - By Associated Press
Gov. Jim Douglas' office says his trip to Asia is paying off, with an agreement with a Korean firm that's expected to bring more than 200 jobs to northern Vermont's Orleans County.
Oct 16 - By Associated Press
Biotech drugmaker Biogen Idec said Friday it has extended its tender offer for shares of Facet Biotech Corp., after the company's board unanimously rejected the hostile takeover bid.
Oct 3 - By Associated Press
The former chief executive of the biotechnology company InterMune Inc. has been convicted of wire fraud in marketing of the drug Actimmune.
Sep 17 - By Wayne Ortman, Associated Press Writer
South Dakota must overcome what university president James Abbott characterized as an inferiority complex if it's to produce college graduates who can grow a biotechnology industry that's already taken root.
Aug 3 - By Alan Fram, Associated Press Writer
With the nation's $46 billion biological drug market at stake, the war between makers of the pricey biotech medicines and their would-be generic competitors has involved millions of dollars in lobbying, thousands in campaign contributions and uncounted visits to members of Congress. And one noteworthy letter.
Aug 3 - By Associated Press
Cardinal Health Inc. said Monday it agreed to buy radiologic imaging company Biotech for an undisclosed amount.
Jun 11 - By Matthew Perrone, AP Business Writer
The biotechnology industry's demand for up to 14 years of competition-free marketing before cheaper copies of their drugs can be launched is unnecessary and would discourage development of new treatments, the Federal Trade Commission told lawmakers Thursday.
Jun 8 - By Matthew Perrone, AP Business Writer
As the Obama administration renews its health care reform effort on Capitol Hill, a top Democrat is calling for speedy action on a yearslong effort to create generic competition for costly biotech drugs.
May 5 - By Associated Press
The U.S. biotech industry became profitable as a whole for the first time in 2008, a new report says, but the global financial crisis has led to a pullback in the investment that drives the industry's expensive research.
Mar 26 - By Matthew Perrone, AP Business Writer
Biotech drugs that now cost thousands of dollars per month would have to compete with lower-cost generic versions after just five years on the market, under a new congressional proposal.
Mar 11 - By Associated Press
A bipartisan group in Congress wants to give the Food and Drug Administration power to approve copies of costly biotech drugs.
Dec 3 - By Sam Hananel, Associated Press Writer
An unauthorized strain of genetically modified cotton was accidentally mixed in with other harvested cotton in Texas last month, but government officials on Wednesday played down any safety concerns.
Oct 21 - By Lindsey Tanner, AP Medical Writer
Nearly a fourth of widely used new-generation biological drugs for several common diseases produce serious side effects that lead to safety warnings soon after they go on the market, the first major study of its kind found.
Sep 22 - By Roxana Hegeman, Associated Press Writer
Biotechnology that allows more profitable corn and soybean crops to thrive in arid fields is encroaching on traditional wheat acreage across the Great Plains, industry experts say.
May 5 - By Constant Brand, Associated Press Writer
Environmental groups appealed to the European Union on Monday to reject applications from the biotech industry to approve one newly engineered potato variety and two corn crops.
Apr 24 - By Associated Press
The California Supreme Court has slashed $200 million from a judgment against Genentech Inc.
Mar 18 - By Paul Elias, Associated Press Writer
The former chief executive of the biotechnology company InterMune Inc. was charged in federal court Tuesday with orchestrating an illegal marketing scheme of the drug Actimmune.
Feb 9 - By Associated Press
The French government on Saturday suspended the use of genetically modified corn crops in France while it awaits EU approval for a full ban.
Jan 23 - By Marcus Wohlsen, Associated Press Writer
California's biotechnology industry is growing steadily, but the looming possibility of increased government oversight could stifle new drug development, according to an industry-supported report set for release Thursday.
Nov 20 - By Marcus Wohlsen, Associated Press Writer
Despite excitement among some scientists — and at the White House — about an embryo-free technique for creating human stem cells, reaction from companies that might turn the research into treatments was muted.
Oct 22 - By Alan Clendenning, Associated Press Writer
Two people were shot dead when activists were confronted by armed men as they invaded a Swiss-owned farm that has been a flashpoint in the debate over biotech crops, authorities and the company said Monday.

Apr 16 - By Lauran Neergaard, AP Medical Writer
A major change in the national diet is under way: Heart-damaging trans fat is rapidly disappearing from grocery aisles and restaurant food, too. But are its replacements really healthier?
Apr 12 - By Rajesh Mahapatra, AP Writer
The United States downplayed prospects for an immediate breakthrough in stalled global trade negotiations as top officials from six member nations of the World Trade Organization headed Thursday for talks in India.

Mar 12 - By Tom Raum, Associated Press Writer
Mexican President Felipe Calderon has a tough message for President Bush: The United States must do more — "much more" — to solve thorny issues of drug-trafficking and immigration. At the last stop on his Latin American tour, Bush must convince Calderon on Tuesday that he's committed to soothing strained U.S.-Mexico relations, which only got worse when Bush signed a law calling for construction of more than 700 miles of new fencing along the long border the two countries share.